These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 37057189)

  • 1. siRNA-Loaded Poly(Histidine-Arginine)6-Modified Chitosan Nanoparticle with Enhanced Cell-Penetrating and Endosomal Escape Capacities for Suppressing Breast Tumor Metastasis [Retraction].
    Int J Nanomedicine; 2023; 18():1897-1898. PubMed ID: 37057189
    [TBL] [Abstract][Full Text] [Related]  

  • 2. siRNA-loaded poly(histidine-arginine)
    Sun P; Huang W; Kang L; Jin M; Fan B; Jin H; Wang QM; Gao Z
    Int J Nanomedicine; 2017; 12():3221-3234. PubMed ID: 28458542
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Novel Nanoemulsion-Based Method to Produce Ultrasmall, Water-Dispersible Nanoparticles from Chitosan, Surface Modified with Cell-Penetrating Peptide for Oral Delivery of Proteins and Peptides [Retraction].
    Int J Nanomedicine; 2022; 17():1461-1462. PubMed ID: 35378883
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhancing endosomal escape for nanoparticle mediated siRNA delivery.
    Ma D
    Nanoscale; 2014 Jun; 6(12):6415-25. PubMed ID: 24837409
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhancing siRNA-based cancer therapy using a new pH-responsive activatable cell-penetrating peptide-modified liposomal system.
    Xiang B; Jia XL; Qi JL; Yang LP; Sun WH; Yan X; Yang SK; Cao DY; Du Q; Qi XR
    Int J Nanomedicine; 2017; 12():2385-2405. PubMed ID: 28405163
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of a novel nanoparticle by dual modification with the pluripotential cell-penetrating peptide PepFect6 for cellular uptake, endosomal escape, and decondensation of an siRNA core complex.
    Mitsueda A; Shimatani Y; Ito M; Ohgita T; Yamada A; Hama S; Gräslund A; Lindberg S; Langel Ü; Harashima H; Nakase I; Futaki S; Kogure K
    Biopolymers; 2013 Nov; 100(6):698-704. PubMed ID: 23893316
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Apigenin-Loaded Solid Lipid Nanoparticle Attenuates Diabetic Nephropathy Induced by Streptozotocin Nicotinamide Through Nrf2/HO-1/NF-kB Signalling Pathway [Retraction].
    Int J Nanomedicine; 2022; 17():3457-3458. PubMed ID: 35959280
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thiolated Chitosan Nanoparticles as a Delivery System for Antisense Therapy: Evaluation against EGFR in T47D Breast Cancer Cells [Retraction].
    Int J Nanomedicine; 2022; 17():3581-3582. PubMed ID: 35983481
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro and in vivo Protein Release and Anti-Ischemia/Reperfusion Injury Properties of Bone Morphogenetic Protein-2-Loaded Glycyrrhetinic Acid-Poly(Ethylene Glycol)-b-Poly(L-Lysine) Nanoparticles [Retraction].
    Int J Nanomedicine; 2022; 17():2609-2610. PubMed ID: 35712640
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficient gene transfection by histidine-modified chitosan through enhancement of endosomal escape.
    Chang KL; Higuchi Y; Kawakami S; Yamashita F; Hashida M
    Bioconjug Chem; 2010 Jun; 21(6):1087-95. PubMed ID: 20499901
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chitosan-based nanoparticles for survivin targeted siRNA delivery in breast tumor therapy and preventing its metastasis.
    Sun P; Huang W; Jin M; Wang Q; Fan B; Kang L; Gao Z
    Int J Nanomedicine; 2016; 11():4931-4945. PubMed ID: 27729789
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhanced endosomal escape by photothermal activation for improved small interfering RNA delivery and antitumor effect.
    Yang X; Fan B; Gao W; Li L; Li T; Sun J; Peng X; Li X; Wang Z; Wang B; Zhang R; Xie J
    Int J Nanomedicine; 2018; 13():4333-4344. PubMed ID: 30087564
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preparation and in vitro Evaluation of Doxorubicin-Loaded Fe
    Int J Nanomedicine; 2020; 15():5573-5574. PubMed ID: 32848388
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of Polymeric Nanoparticle Intracellular Targeting Overcomes Chemodrug Resistance in Human Primary Patient Breast Cancer Cells [Retraction].
    Int J Nanomedicine; 2022; 17():2555-2556. PubMed ID: 35685301
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumour-Targeted and Redox-Responsive Mesoporous Silica Nanoparticles for Controlled Release of Doxorubicin and an siRNA Against Metastatic Breast Cancer [Retraction].
    Int J Nanomedicine; 2022; 17():2319-2320. PubMed ID: 35637839
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The spacer arm length in cell-penetrating peptides influences chitosan/siRNA nanoparticle delivery for pulmonary inflammation treatment.
    Jeong EJ; Choi M; Lee J; Rhim T; Lee KY
    Nanoscale; 2015 Dec; 7(47):20095-104. PubMed ID: 26568525
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiviral Activity of Chitosan Nanoparticles Encapsulating Curcumin Against Hepatitis C Virus Genotype 4a in Human Hepatoma Cell Lines [Retraction].
    Int J Nanomedicine; 2022; 17():2891-2892. PubMed ID: 35818402
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endosomolytic and Tumor-Penetrating Mesoporous Silica Nanoparticles for siRNA/miRNA Combination Cancer Therapy.
    Wang Y; Xie Y; Kilchrist KV; Li J; Duvall CL; Oupický D
    ACS Appl Mater Interfaces; 2020 Jan; 12(4):4308-4322. PubMed ID: 31939276
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rational modification of oligoarginine for highly efficient siRNA delivery: structure-activity relationship and mechanism of intracellular trafficking of siRNA.
    Chu D; Xu W; Pan R; Ding Y; Sui W; Chen P
    Nanomedicine; 2015 Feb; 11(2):435-46. PubMed ID: 25193363
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Formulation and in vitro evaluation of a siRNA delivery nanosystem decorated with gH625 peptide for triple negative breast cancer theranosis.
    Ben Djemaa S; David S; Hervé-Aubert K; Falanga A; Galdiero S; Allard-Vannier E; Chourpa I; Munnier E
    Eur J Pharm Biopharm; 2018 Oct; 131():99-108. PubMed ID: 30063968
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.